AMGEN INC Quarterly Costs and Expenses in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Amgen Inc quarterly/annual Costs and Expenses history and growth rate from Q1 2010 to Q3 2024.
  • Amgen Inc Costs and Expenses for the quarter ending September 30, 2024 was $6.46B, a 32.2% increase year-over-year.
  • Amgen Inc Costs and Expenses for the twelve months ending September 30, 2024 was $26.3B, a 46.4% increase year-over-year.
  • Amgen Inc annual Costs and Expenses for 2023 was $20.3B, a 21.1% increase from 2022.
  • Amgen Inc annual Costs and Expenses for 2022 was $16.8B, a 8.63% decline from 2021.
  • Amgen Inc annual Costs and Expenses for 2021 was $18.3B, a 12.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $26.3B $6.46B +$1.57B +32.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $24.7B $6.48B +$2.18B +50.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $22.6B $6.46B +$2.27B +54.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $20.3B $6.93B +$2.32B +50.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-14
Q3 2023 $18B $4.88B +$890M +22.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $17.1B $4.3B -$116M -2.63% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $17.2B $4.18B +$446M +11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
Q4 2022 $16.8B $4.61B +$67M +1.48% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $16.7B $3.99B -$336M -7.76% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $17B $4.42B -$1.28B -22.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $18.3B $3.74B -$34M -0.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $18.3B $4.54B -$84M -1.82% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-14
Q3 2021 $18.4B $4.33B +$358M +9.02% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $18.1B $5.7B +$1.82B +46.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $16.3B $3.77B -$34M -0.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-28
Q4 2020 $16.3B $4.63B +$477M +11.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-09
Q3 2020 $15.8B $3.97B +$709M +21.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $15.1B $3.88B +$690M +21.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 $14.4B $3.81B +$721M +23.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-28
Q4 2019 $13.7B $4.15B +$301M +7.82% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-16
Q3 2019 $13.4B $3.26B -$320M -8.94% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 $13.7B $3.19B -$34M -1.05% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $13.7B $3.09B +$257M +9.09% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $13.5B $3.85B +$291M +8.18% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-09
Q3 2018 $13.2B $3.58B +$247M +7.41% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 $12.9B $3.23B +$115M +3.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $12.8B $2.83B -$45M -1.57% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-01
Q4 2017 $12.9B $3.56B +$77M +2.21% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-12
Q3 2017 $12.8B $3.33B +$50M +1.52% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-31
Q2 2017 $12.7B $3.11B -$196M -5.93% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-27
Q1 2017 $12.9B $2.87B -$252M -8.06% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-25
Q4 2016 $13.2B $3.48B -$23M -0.66% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $13.2B $3.28B -$100M -2.96% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-26
Q2 2016 $13.3B $3.31B +$14M +0.43% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-26
Q1 2016 $13.3B $3.13B +$114M +3.79% Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-27
Q4 2015 $13.2B $3.5B -$369M -9.53% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-13
Q3 2015 $13.6B $3.38B -$181M -5.08% Jul 1, 2015 Sep 30, 2015 10-Q 2016-10-28
Q2 2015 $13.7B $3.29B +$16M +0.49% Apr 1, 2015 Jun 30, 2015 10-Q 2016-07-29
Q1 2015 $13.7B $3.01B -$146M -4.63% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $13.9B $3.87B +$48M +1.26% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-14
Q3 2014 $13.8B $3.57B +$505M +16.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $13.3B $3.28B +$149M +4.76% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $13.2B $3.16B +$361M +12.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-27
Q4 2013 $12.8B $3.82B +$491M +14.7% Oct 1, 2013 Dec 31, 2013 8-K 2016-10-31
Q3 2013 $12.3B $3.06B +$164M +5.66% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-29
Q2 2013 $12.2B $3.13B +$241M +8.35% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-05
Q1 2013 $11.9B $2.8B +$225M +8.75% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-30
Q4 2012 $11.7B $3.33B +$522M +18.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 $11.2B $2.9B -$523M -15.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-29
Q2 2012 $11.7B $2.89B +$261M +9.94% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $11.4B $2.57B +$158M +6.55% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 $11.3B $2.81B +$38M +1.37% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-24
Q3 2011 $11.2B $3.42B +$1.08B +46.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $10.2B $2.63B +$340M +14.9% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 $9.81B $2.41B +$302M +14.3% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q4 2010 $9.51B $2.77B Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $2.34B Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $2.29B Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $2.11B Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.